Author: OurCrowd

Where We’ve Been: OurCrowd events quarterly update for July-August-September

Where We’ve Been: OurCrowd events quarterly update for July-August-September

Oct 2, 2014 | ,

It’s been a busy few months at OurCrowd! Throughout July-August-September OurCrowd has hosted numerous events worldwide and we wanted to take a moment to look back at where we were, who we invested in and see where we’re going to be next quarter. We’re so proud of what the OurCrowd community has accomplished over the past three months — from events hosted to the companies funded — and are looking forward to continuing on this journey together in the months to come. Without further ado, here is a glimpse into all the excitement happening at OurCrowd: Where We’ve Been Over the course of the past three months, OurCrowd founder & CEO Jon Medved and team members have traveled the world, hosting various events with the CEOs of our latest startups and guest speakers. We’ve held a total of 14 events, in 10 different cities, across 4 continents! In case you missed them, here are some event highlights: July 1st – Kicking off the quarter, OurCrowd held an exclusive investor event in Paris, France. Hosted by Ayache Salama & Associés, attendees enjoyed a nice...

Read More
GE Ventures makes first investment via equity crowdfunding platform, OurCrowd

GE Ventures makes first investment via equity crowdfunding platform, OurCrowd

Oct 2, 2014 | , , , ,

We’re proud to announce that MedAware, an OurCrowd portfolio company, has closed its investment of $1 million from GE Ventures and OurCrowd investors. This financing round marks the first investment the venture capital arm of GE, GE Ventures, has made as part of the strategic co-investment partnership OurCrowd signed with the firm back in November 2013. We believe we have reached a real milestone and transformative moment in the world of high-tech finance. This investment underscores the fact that the startup investment playing field is being levelled — OurCrowd investors get access to the same deals multi-billion dollar corporations are seeing, at the same terms. We are looking forward to driving innovation forward with GE Ventures, whose unequalled expertise and experience in a broad range of technologies and businesses add real value to our portfolio companies and to our investor community. “We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology,” said Jon Medved, founder and CEO of OurCrowd. “The fact that our partner, General Electric, has joined together with us in...

Read More

OurCrowd’s portfolio company BioCatch featured on Bloomberg TV

Oct 2, 2014 | ,

OurCrowd portfolio company BioCatch was featured on Bloomberg Television’s “The Pulse.” In the interview, Benny Rosenbaum, Chief Executive Officer at BioCatch, talks with Elliott Gotkine about turning online fraud into art as they visualize the trails left behind by criminals on computers. BioCatch raised $3,334,500 from OurCrowd investors in February 2014. View the video below or play it on Bloomberg...

Read More

OurCrowd’s portfolio company EdenShield featured in The Huffington Post

Oct 2, 2014 | ,

OurCrowd portfolio company EdenShield was featured in The Huffington Post, a leading online news source, content aggregator and blog. EdenShield are the producers of a novel plant extract from the Israeli Judean Desert that makes crops odorless to pests, preventing multi-billion dollar crop damage. While traditional farmers may be slow to adopt EdenShield’s natural extracts, grown and extracted in Israel and then used on netting in the field or applied in the greenhouse, large grow operations for medical cannabis have been taking note. The team is currently trying their product in Israel and in Africa and are farming the natural substance (plant name is secret) in the northeast Negev Desert. In a kibbutz. They have recently expanded their production from 3 to 30 dunams and are anticipating $1 million USD in sales next year. EdenShield raised $712,000 from OurCrowd investors in 2014. Read more on The Huffington...

Read More

OurCrowd’s portfolio company MedAware featured in Globes

Oct 2, 2014 | ,

OurCrowd portfolio company MedAware was featured in Globes, the leading Israeli financial daily. Medication errors greatly affect a vast number of people and institutions, harming an estimated 1.5 million Americans each year. Medaware seeks to provide better preventative services than other prescription reviewing systems. MedAware has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs by combating prescription errors. MedAware Co-Founder and CEO Gidi Stein said, “Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug. The ease with which a little boy died because of a mistaken click of a button was horrifying to me as a physician and as a parent. We have founded MedAware in order to try and prevent such cases.” MedAware raised $1 million from GE Ventures and OurCrowd investors in 2014. Read more on...

Read More